Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 2-deoxy-2-fluoro-alpha-D-mannosyl fluoride is a synthetic fluorinated sugar analog of mannose. It is classified as a small molecule and has the molecular formula C6H10F2O4. This compound is primarily used in biochemical research as an inhibitor or substrate analog for glycosidases and glycosyltransferases due to its structural similarity to natural mannose but with enhanced stability from the fluorine substitution. The presence of both a deoxy and fluoro group at the C‑2 position makes it resistant to enzymatic hydrolysis compared to native sugars. Its mechanism of action involves acting as a competitive inhibitor or mechanism-based inactivator for enzymes that process mannose-containing substrates[1][3][7]. There are no approved therapeutic indications; it is considered experimental.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-deoxy-2-fluoro-alpha-D-mannosyl fluoride.